Trial in progress: Phase 2 study of intratumoral plasmid interleukin-12 (tavokinogene telseplasmid; TAVO (TM)) plus electroporation in combination with pembrolizumab with or without chemotherapy in patients with inoperable locally advanced or metastatic triple-negative breast cancer (KEYNOTE-890/OMS-I141)-MedSci.cn

Trial in progress: Phase 2 study of intratumoral plasmid interleukin-12 (tavokinogene telseplasmid; TAVO (TM)) plus electroporation in combination with pembrolizumab with or without chemotherapy in patients with inoperable locally advanced or metastatic triple-negative breast cancer (KEYNOTE-890/OMS-I141)

Telli, M; Devitt, B; Cuff, K; Vinayak, S; Nanda, R; Montero, AJ; Hui, R; Canton, DA; Twitty, C; Xie, S; Bannavong, D; O'Keeffe, B; Aung, S; Joshi, R

CANCER RESEARCH, 2022; 82 (4):

科室
- - 订阅+
  - 更多科室
工具
服务